rheumatology
Medicines

Consumer watchdog seeks heavier penalty for Nurofen manufacturer

The ACCC has launched an appeal into the size of a recent Federal Court penalty for Nurofen manufacturer Reckitt Benckiser, ­saying it fails to act as an ­adequate deterrent. The Federal Court delivered a $1.7 million penalty to the pharmaceutical company last month for misleading customers in its pain relief packaging. However the consumer watch dog ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic